DE3461803D1
(en)
*
|
1983-05-23 |
1987-02-05 |
Pfizer |
Antibacterial cyclic ethers of 9-deoxo-9a-aza-9a-homoerythromycin a and intermediates therefor
|
US4464527A
(en)
*
|
1983-06-30 |
1984-08-07 |
Pfizer Inc. |
Antibacterial 9-deoxo-9a-alkyl-9a-aza-9a-homoerythromycin A derivatives and intermediates therefore
|
US4465674A
(en)
*
|
1983-09-06 |
1984-08-14 |
Pfizer Inc. |
Azahomoerythromycin D derivative and intermediates therefor
|
EP0136831B1
(en)
*
|
1983-09-06 |
1988-11-09 |
Pfizer Inc. |
Azahomoerythromycin b derivatives and intermediates thereof
|
US4518590A
(en)
*
|
1984-04-13 |
1985-05-21 |
Pfizer Inc. |
9α-Aza-9α-homoerythromycin compounds, pharmaceutical compositions and therapeutic method
|
YU44599B
(en)
*
|
1986-09-12 |
1990-10-31 |
Pliva Pharm & Chem Works |
Process for preparing complex of n-methyl-11-aza-10-deoxo-10-dihydroeritromicine a and 11-aza-10-deoxo-10-dihydroeritromicine a with metals
|
MX12213A
(es)
*
|
1987-07-09 |
1993-05-01 |
Pfizer |
Metodo de preparacion de dihidrato de azitromicina cristalino
|
WO1989002271A1
(en)
*
|
1987-09-10 |
1989-03-23 |
Pfizer |
Azithromycin and derivatives as antiprotozoal agents
|
WO1989004167A1
(en)
*
|
1987-11-10 |
1989-05-18 |
Pfizer Inc. |
Antibacterial 9-deoxo-9a-allyl and propargyl-9a-aza-9a-homoerythromycin a derivatives
|
US5837691A
(en)
*
|
1988-08-03 |
1998-11-17 |
Schering Corporation |
Actinomadura vulgaris subsp vulgaris and antimicrobial complex and antimicrobial
|
SI9011409A
(en)
*
|
1990-07-18 |
1995-10-31 |
Pliva Pharm & Chem Works |
O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
|
US5912331A
(en)
*
|
1991-03-15 |
1999-06-15 |
Merck & Co., Inc. |
Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
|
CA2064634C
(en)
|
1991-04-04 |
1998-08-04 |
James V. Heck |
9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
|
US5985844A
(en)
*
|
1992-03-26 |
1999-11-16 |
Merck & Co., Inc. |
Homoerythromycin A derivatives modified at the 4"-and 8A-positions
|
US5189159A
(en)
*
|
1992-04-02 |
1993-02-23 |
Merck & Co., Inc. |
8a-AZA-8a-homoerythromycin cyclic iminoethers
|
US5215980A
(en)
*
|
1992-01-17 |
1993-06-01 |
Merck & Co., Inc. |
10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof
|
TW271400B
(fi)
*
|
1992-07-30 |
1996-03-01 |
Pfizer |
|
US5210235A
(en)
*
|
1992-08-26 |
1993-05-11 |
Merck & Co., Inc. |
Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
|
HRP930014A2
(en)
*
|
1993-01-08 |
1994-08-31 |
Pliva Pharm & Chem Works |
9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
|
US5332807A
(en)
*
|
1993-04-14 |
1994-07-26 |
Merck & Co., Inc. |
Process of producing 8A- and 9A-azalide antibiotics
|
ES2104386T3
(es)
*
|
1993-05-19 |
1997-10-01 |
Pfizer |
Compuesto intermedio para la acitromicina.
|
US5441939A
(en)
*
|
1994-03-04 |
1995-08-15 |
Pfizer Inc. |
3"-desmethoxy derivatives of erythromycin and azithromycin
|
HRP940251B1
(en)
*
|
1994-04-15 |
1998-12-31 |
Stjepan Mutak |
Process for the preparation of azithromycin dihydrochloride
|
US5605889A
(en)
*
|
1994-04-29 |
1997-02-25 |
Pfizer Inc. |
Method of administering azithromycin
|
US6068859A
(en)
|
1994-05-06 |
2000-05-30 |
Pfizer Inc. |
Controlled-release dosage forms of Azithromycin
|
PT102006B
(pt)
*
|
1997-05-19 |
2000-06-30 |
Hovione Sociedade Quimica S A |
Novo processo de preparacao de azitromicina
|
HN1998000086A
(es)
*
|
1997-06-11 |
1999-03-08 |
Pfizer Prod Inc |
Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
|
HN1998000074A
(es)
*
|
1997-06-11 |
1999-01-08 |
Pfizer Prod Inc |
Derivados de macrolidos c-4 sustituidos
|
JP2003512290A
(ja)
*
|
1997-09-10 |
2003-04-02 |
メルク エンド カムパニー インコーポレーテッド |
家畜抗菌剤としての8a−アザライド
|
ATE348836T1
(de)
*
|
1997-10-16 |
2007-01-15 |
Glaxosmithkline Zagreb |
Neue 3,6-hemiketale der 9a-azalidklasse
|
US6861411B1
(en)
|
1997-12-02 |
2005-03-01 |
Pfizer, Inc. |
Method of treating eye infections with azithromycin
|
DE69825128T3
(de)
*
|
1997-12-02 |
2010-05-06 |
Pfizer Products Inc., Groton |
Verwendung von azithromycin zur topischen behandlung von augeninfektionen
|
AP9801420A0
(en)
*
|
1998-01-02 |
1998-12-31 |
Pfizer Prod Inc |
Novel macrolides.
|
AP1060A
(en)
|
1998-01-02 |
2002-04-23 |
Pfizer Prod Inc |
Novel erythromycin derivatives.
|
TW546302B
(en)
|
1998-05-08 |
2003-08-11 |
Biochemie Sa |
Improvements in macrolide production
|
CA2245398C
(en)
|
1998-08-21 |
2002-01-29 |
Apotex Inc. |
Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
|
EP1115732B1
(en)
|
1998-09-22 |
2005-06-29 |
Pfizer Products Inc. |
Carbamate and carbazate ketolide antibiotics
|
JP4043191B2
(ja)
*
|
1998-11-03 |
2008-02-06 |
ファイザー・プロダクツ・インク |
新規なマクロライド抗生物質
|
UA70972C2
(uk)
*
|
1998-11-20 |
2004-11-15 |
Пфайзер Продактс Інк. |
13-членні азаліди і їх застосування як антибіотиків
|
WO2000032203A1
(en)
*
|
1998-11-30 |
2000-06-08 |
Teva Pharmaceutical Industries Ltd. |
Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
|
ES2273964T3
(es)
|
1998-12-10 |
2007-05-16 |
Pfizer Products Inc. |
Antibioticos de carbamato y carbazato cetolida.
|
ID30233A
(id)
*
|
1999-01-27 |
2001-11-15 |
Pfizer Prod Inc |
Antibiotika ketolida
|
US6239113B1
(en)
|
1999-03-31 |
2001-05-29 |
Insite Vision, Incorporated |
Topical treatment or prevention of ocular infections
|
US7056893B2
(en)
*
|
1999-03-31 |
2006-06-06 |
Insite Vision, Inc. |
Topical treatment for prevention of ocular infections
|
US6939861B2
(en)
*
|
1999-04-16 |
2005-09-06 |
Kosan Biosciences, Inc. |
Amido macrolides
|
PL352720A1
(en)
*
|
1999-05-24 |
2003-09-08 |
Pfizer Products Inc. |
13-methyl-erythromycin derivatives
|
US6465437B1
(en)
*
|
1999-06-30 |
2002-10-15 |
Pfizer Inc. |
Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
|
US6764996B1
(en)
|
1999-08-24 |
2004-07-20 |
Abbott Laboratories |
9a-azalides with antibacterial activity
|
DK1206476T3
(da)
*
|
1999-08-24 |
2006-05-15 |
Abbott Lab |
9a-azalider med antibakteriel virkning
|
EP1101769A3
(en)
|
1999-11-18 |
2001-10-24 |
Pfizer Products Inc. |
Nitrogen containing erythromycin derivatives
|
ES2177373B1
(es)
|
1999-11-26 |
2003-11-01 |
Astur Pharma Sa |
Preparacion de azitromicina en su forma no cristalina
|
DE60133083D1
(de)
*
|
2000-01-04 |
2008-04-17 |
Teva Pharma |
Verfahren zur herstellung von azithromycin-dihydrat
|
IL141438A0
(en)
*
|
2000-02-23 |
2002-03-10 |
Pfizer Prod Inc |
Method of increasing the bioavailability and tissue penetration of azithromycin
|
US6544555B2
(en)
|
2000-02-24 |
2003-04-08 |
Advancis Pharmaceutical Corp. |
Antibiotic product, use and formulation thereof
|
US6565882B2
(en)
|
2000-02-24 |
2003-05-20 |
Advancis Pharmaceutical Corp |
Antibiotic composition with inhibitor
|
US20030213724A1
(en)
*
|
2000-03-20 |
2003-11-20 |
Sven Dobler |
Fragrance sampler insert
|
US6403776B1
(en)
|
2000-07-05 |
2002-06-11 |
Pfizer Inc. |
Synthesis of carbamate ketolide antibiotics
|
CA2417353C
(en)
|
2000-07-25 |
2009-09-01 |
Laboratorio Silanes,S.A. De C.V. |
Single-step process for preparing 7,16-deoxy-2-aza-10-o-cladinosil-12-o-desosaminil-4,5-dihydroxi-6-ethyl-3,5,9,11,13,15-hexamethylbicycle (11.2.1)hexadeca-1(2)-en-8-one, and obtaining a new form of 9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a
|
US20020115621A1
(en)
*
|
2000-08-07 |
2002-08-22 |
Wei-Gu Su |
Macrolide antibiotics
|
AU2001280000A1
(en)
*
|
2000-08-23 |
2002-03-04 |
Jaweed Mukarram, Siddiqui Mohammed |
Process for preparation of anhydrous azithromycin
|
US20020068078A1
(en)
|
2000-10-13 |
2002-06-06 |
Rudnic Edward M. |
Antifungal product, use and formulation thereof
|
US6541014B2
(en)
|
2000-10-13 |
2003-04-01 |
Advancis Pharmaceutical Corp. |
Antiviral product, use and formulation thereof
|
CA2429639C
(en)
|
2000-11-27 |
2009-07-14 |
Biochemie S.A. |
Stable azithromycin monohydrate
|
JP4104463B2
(ja)
|
2001-04-27 |
2008-06-18 |
ファイザー・プロダクツ・インク |
4’’−置換された−9−デオキソ−9a−アザ−9a−ホモエリスロマイシン誘導体を製造するための方法
|
PL367091A1
(en)
*
|
2001-05-22 |
2005-02-21 |
Pfizer Products Inc. |
Crystal forms of azithromycin
|
EP1652851A1
(en)
|
2001-05-22 |
2006-05-03 |
Pfizer Products Inc. |
New crystal form of Azithromycin
|
US6861413B2
(en)
*
|
2001-05-22 |
2005-03-01 |
Pfizer Inc. |
Stable non-dihydrate azithromycin oral suspensions
|
CZ2004232A3
(cs)
*
|
2001-08-21 |
2005-10-12 |
Pfizer Products Inc. |
Jednorázová dávka azithromycinu
|
EP1446010B1
(en)
*
|
2001-10-18 |
2009-04-15 |
Teva Pharmaceutical Industries Ltd. |
Stabilized azithromycin compositions
|
US20080149521A9
(en)
*
|
2001-10-18 |
2008-06-26 |
Michael Pesachovich |
Methods of stabilizing azithromycin
|
EP1455757A2
(en)
*
|
2001-12-21 |
2004-09-15 |
Pfizer Products Inc. |
Methods for wet granulating azithromycin
|
AU2002348884A1
(en)
*
|
2001-12-21 |
2003-07-09 |
Pfizer Products Inc. |
Directly compressible formulations of azithromycin
|
US8063021B2
(en)
*
|
2002-01-17 |
2011-11-22 |
Kosan Biosciences Incorporated |
Ketolide anti-infective compounds
|
MXPA04007427A
(es)
*
|
2002-02-01 |
2004-10-11 |
Pfizer Prod Inc |
Formulaciones de azitromicina granuladas por via seca.
|
US20040186063A1
(en)
*
|
2002-02-15 |
2004-09-23 |
Hans-Jurgen Gutke |
Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
|
WO2003070254A1
(en)
*
|
2002-02-15 |
2003-08-28 |
Sympore Gmbh |
Antibiotic conjugates
|
US7579324B2
(en)
|
2002-02-15 |
2009-08-25 |
C-A-I-R Biosciences Gmbh |
Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
|
US20040005641A1
(en)
*
|
2002-02-15 |
2004-01-08 |
Michael Burnet |
Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
|
AU2003211668A1
(en)
*
|
2002-02-26 |
2003-09-09 |
Meiji Seika Kaisha, Ltd. |
Novel 15-membered cyclic azalide, novel 16-membered cyclic diazalide derivative, and process for producing these
|
ITMI20021209A1
(it)
*
|
2002-06-04 |
2003-12-04 |
Chemi Spa |
Processo di preparazione di azitromicina ad elevata purezza
|
US20040043073A1
(en)
*
|
2002-06-14 |
2004-03-04 |
Chih-Ming Chen |
Pharmaceutical compositions for drugs having pH-dependent solubility
|
WO2004005313A2
(en)
*
|
2002-07-08 |
2004-01-15 |
Pliva - Istrazivacki Institut D.O.O. |
Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules
|
US7109176B2
(en)
*
|
2002-07-08 |
2006-09-19 |
Pliva-Istrazivacki Institut D.O.O. |
Nonsteroidal anti-inflammatory substances, compositions and methods for their use
|
US7091187B2
(en)
*
|
2002-07-08 |
2006-08-15 |
Pliva-Istrazivacki Institut D.O.O. |
Compounds, compositions and methods for treatment of inflammatory diseases and conditions
|
HRP20020885B1
(en)
*
|
2002-11-11 |
2007-05-31 |
GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. |
SUBSTITUTED 9a-N-{N'-[4-(SULFONYL)PHENYLCARBAMOYL]}DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERITHROMYCIN A AND 5-O-DESOZAMINYL-9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERITHRONOLIDE A
|
HRP20020991A2
(en)
*
|
2002-12-12 |
2005-02-28 |
Pliva-Istra�iva�ki institut d.o.o. |
N"-Substituted 9a-N-(N'-carbamoyl-Gamma-aminopropyl), 9a-N-(N'? -thiocarbamoyl-Gamma-aminopropyl), 9a-N-(N'-((Beta-cyanoethyl)-N'-carbamoyl-Gamma? -aminopropyl) and 9a-N-(N'-(Beta-cyanoethyl)-N'-thiocarbamoyl-Gamma? -aminopropyl) derivatives of 9-de
|
WO2004080391A2
(en)
|
2003-03-10 |
2004-09-23 |
Optimer Pharmaceuticals, Inc. |
Novel antibacterial agents
|
US20040266997A1
(en)
*
|
2003-03-25 |
2004-12-30 |
Michael Pesachovich |
Degradation products of azithromycin, and methods for their indentification
|
ES2220229B1
(es)
*
|
2003-05-29 |
2005-10-16 |
Quimica Sintetica, S.A. |
Sales de adicion de azitromicina y acido citrico y procedimiento para su obtencion.
|
EP2535042A1
(en)
*
|
2003-06-16 |
2012-12-19 |
ANDRX Pharmaceuticals LLC. |
Oral sustained-release composition comprising a macrolide
|
US20050013835A1
(en)
*
|
2003-07-15 |
2005-01-20 |
Pfizer Inc. |
Stable non-dihydrate azithromycin oral suspensions
|
WO2005009364A2
(en)
|
2003-07-21 |
2005-02-03 |
Advancis Pharmaceutical Corporation |
Antibiotic product, use and formulation thereof
|
AU2004258949B2
(en)
|
2003-07-21 |
2011-02-10 |
Shionogi, Inc. |
Antibiotic product, use and formulation thereof
|
JP2006528190A
(ja)
|
2003-07-21 |
2006-12-14 |
アドバンシス ファーマスーティカル コーポレイション |
抗生物質製剤、その使用法及び作成方法
|
JP2007502296A
(ja)
|
2003-08-11 |
2007-02-08 |
アドバンシス ファーマスーティカル コーポレイション |
ロバストペレット
|
JP2007502294A
(ja)
|
2003-08-12 |
2007-02-08 |
アドバンシス ファーマスーティカル コーポレイション |
抗生物質製剤、その使用法及び作成方法
|
EP1661904A1
(en)
*
|
2003-08-22 |
2006-05-31 |
Meiji Seika Kaisha Ltd. |
Novel azalide and azalactam derivatives and process for the production of the same
|
JP5686494B2
(ja)
*
|
2003-08-29 |
2015-03-18 |
シオノギ インコーポレイテッド |
抗生物質製剤、その使用法及び作成方法
|
CN1313476C
(zh)
*
|
2003-09-09 |
2007-05-02 |
上海新先锋药业有限公司 |
阿奇霉素的水溶性磷酸盐的注射剂型及其制备方法
|
AU2004273830B2
(en)
|
2003-09-15 |
2011-03-24 |
Shionogi, Inc. |
Antibiotic product, use and formulation thereof
|
US7276487B2
(en)
*
|
2003-09-23 |
2007-10-02 |
Enanta Pharmaceuticals, Inc. |
9a, 11-3C-bicyclic 9a-azalide derivatives
|
US20050101547A1
(en)
*
|
2003-11-06 |
2005-05-12 |
Sadatrezaei Mohsen |
Stabilized azithromycin composition
|
JP2007513139A
(ja)
*
|
2003-12-04 |
2007-05-24 |
ファイザー・プロダクツ・インク |
安定性の改善した多粒子組成物
|
AU2004294818A1
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Azithromycin multiparticulate dosage forms by liquid-based processes
|
JP2007513145A
(ja)
|
2003-12-04 |
2007-05-24 |
ファイザー・プロダクツ・インク |
医薬用多微粒子の製造方法
|
WO2005053639A2
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Controlled release multiparticulates formed with dissolution enhancers
|
US6984403B2
(en)
*
|
2003-12-04 |
2006-01-10 |
Pfizer Inc. |
Azithromycin dosage forms with reduced side effects
|
WO2005053652A1
(en)
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
|
KR20080064209A
(ko)
*
|
2003-12-04 |
2008-07-08 |
화이자 프로덕츠 인코포레이티드 |
바람직하게는 폴록사머와 글리세라이드를 함유하는다미립자 아지트로마이신 조성물의 제조를 위해 압출기를사용하는 분무응결 방법
|
JP2007513147A
(ja)
|
2003-12-04 |
2007-05-24 |
ファイザー・プロダクツ・インク |
押し出し機を使用して、好ましくはポロキサマーとグリセリドを含有する多粒子結晶性医薬組成物を製造するための噴霧凝結方法
|
US7943585B2
(en)
|
2003-12-22 |
2011-05-17 |
Sandoz, Inc. |
Extended release antibiotic composition
|
US7468428B2
(en)
|
2004-03-17 |
2008-12-23 |
App Pharmaceuticals, Llc |
Lyophilized azithromycin formulation
|
KR101130252B1
(ko)
*
|
2004-07-02 |
2012-03-26 |
와카모토 세이야꾸 가부시끼가이샤 |
아지스로마이신 함유 수성 의약 조성물 및 그 조제 방법
|
AU2005269981A1
(en)
|
2004-07-02 |
2006-02-09 |
Bonck, John A |
Tablet for pulsed delivery
|
US20060183696A1
(en)
*
|
2004-08-12 |
2006-08-17 |
Pliva-Istrazivacki Institut D.O.O. |
Use of immune cell specific conjugates for treatment of inflammatory diseases of gastrointestinal tract
|
EP1778292A2
(en)
*
|
2004-08-12 |
2007-05-02 |
GlaxoSmithKline istrazivacki centar Zagreb d.o.o. |
Use of cell-specific conjugates for treatment of inflammatory diseases of the gastrointestinal tract
|
US7683162B2
(en)
*
|
2004-08-30 |
2010-03-23 |
Taro Pharmaceutical Industries Limited |
Process of preparing a crystalline azithromycin monohydrate
|
US20060046970A1
(en)
*
|
2004-08-31 |
2006-03-02 |
Insite Vision Incorporated |
Topical otic compositions and methods of topical treatment of prevention of otic infections
|
PL1836211T3
(pl)
*
|
2004-12-21 |
2010-07-30 |
Pfizer Prod Inc |
Makrolidy
|
EP1830860A2
(en)
*
|
2004-12-21 |
2007-09-12 |
Pfizer Products Incorporated |
Stable non-dihydrate azithromycin oral suspensions
|
US20090318375A1
(en)
*
|
2005-06-08 |
2009-12-24 |
Hanmi Pharm Co., Ltd |
Crystalline Azithromycin L-Malate Monohydrate and Pharmaceutical Composition Containing Same
|
CN101228171A
(zh)
*
|
2005-07-26 |
2008-07-23 |
默克勒有限公司 |
作为5-脂氧化酶和环加氧酶抑制剂的吡咯里嗪和中氮茚化合物的大环内酯偶联物
|
US8357394B2
(en)
|
2005-12-08 |
2013-01-22 |
Shionogi Inc. |
Compositions and methods for improved efficacy of penicillin-type antibiotics
|
US8778924B2
(en)
|
2006-12-04 |
2014-07-15 |
Shionogi Inc. |
Modified release amoxicillin products
|
WO2007091393A1
(ja)
*
|
2006-02-07 |
2007-08-16 |
Taisho Pharmaceutical Co., Ltd. |
10a-アザライド化合物
|
US8299052B2
(en)
*
|
2006-05-05 |
2012-10-30 |
Shionogi Inc. |
Pharmaceutical compositions and methods for improved bacterial eradication
|
US7704959B2
(en)
|
2006-10-03 |
2010-04-27 |
Dow Pharmaceutical Sciences |
Azithromycin for the treatment of nodular acne
|
WO2009019868A1
(ja)
|
2007-08-06 |
2009-02-12 |
Taisho Pharmaceutical Co., Ltd. |
10a、12位架橋型10a-アザライド化合物
|
US8124123B2
(en)
*
|
2007-09-05 |
2012-02-28 |
Dow Pharmaceutical Sciences, Inc. |
Controlled release azithromycin solid dosages forms
|
US9453042B2
(en)
|
2007-10-25 |
2016-09-27 |
Cempra Pharmaceuticals, Inc. |
Process for the preparation of macrolide antibacterial agents
|
WO2009139181A1
(ja)
|
2008-05-15 |
2009-11-19 |
大正製薬株式会社 |
4員環構造を有する10a-アザライド化合物
|
WO2010048600A1
(en)
*
|
2008-10-24 |
2010-04-29 |
Cempra Pharmaceuticals, Inc. |
Methods for treating resistant diseases using triazole containing macrolides
|
US20170128481A9
(en)
|
2009-03-06 |
2017-05-11 |
Insite Vision Corporation |
Ocular treatment with reduced intraocular pressure
|
CN102413826A
(zh)
|
2009-03-13 |
2012-04-11 |
达·沃尔泰拉公司 |
用于消除革兰氏阴性菌的组合物和方法
|
US9937194B1
(en)
|
2009-06-12 |
2018-04-10 |
Cempra Pharmaceuticals, Inc. |
Compounds and methods for treating inflammatory diseases
|
WO2011015219A1
(en)
|
2009-08-06 |
2011-02-10 |
Shifa Pharmed Industrial Group Co. |
Process for the purification of azithromycin by separation from its thermal degradation products and/or isomers
|
WO2011032052A1
(en)
|
2009-09-10 |
2011-03-17 |
Cempra Pharmaceuticals, Inc. |
Methods for treating malaria, tuberculosis and mac diseases
|
DK2550286T3
(en)
|
2010-03-22 |
2016-02-29 |
Cempra Pharmaceuticals Inc |
CRYSTALLINE FORMS OF A MACROLID AND APPLICATIONS THEREOF
|
EP2571506B1
(en)
|
2010-05-20 |
2017-05-10 |
Cempra Pharmaceuticals, Inc. |
Processes for preparing macrolides and ketolides and intermediates therefor
|
WO2012034058A1
(en)
|
2010-09-10 |
2012-03-15 |
Cempra Pharmaceuticals, Inc. |
Hydrogen bond forming fluoro ketolides for treating diseases
|
AR085286A1
(es)
|
2011-02-21 |
2013-09-18 |
Taisho Pharmaceutical Co Ltd |
Derivado de macrolido sustituido en la posicion c-4
|
WO2013088274A1
(en)
|
2011-12-14 |
2013-06-20 |
Wockhardt Limited |
Anhydrous amorphous azithromycin composition free of azithromycin dihydrate
|
RU2658050C2
(ru)
|
2012-03-27 |
2018-06-19 |
Семпра Фармасьютикалз, Инк. |
Парентеральные составы для введения макролидных антибиотиков
|
US10987370B2
(en)
|
2012-12-24 |
2021-04-27 |
Ramot At Tel-Aviv University Ltd. |
Methods of inducing read-through of a nonsense mutation associated with ataxia telangiectasia, Rett syndrome or spinal muscular atrophy by erythromycin or azithromycin
|
AU2014239959A1
(en)
|
2013-03-14 |
2015-10-01 |
Cempra Pharmaceuticals, Inc. |
Methods for treating respiratory diseases and formulations therefor
|
US9751908B2
(en)
|
2013-03-15 |
2017-09-05 |
Cempra Pharmaceuticals, Inc. |
Convergent processes for preparing macrolide antibacterial agents
|
US9044508B2
(en)
|
2013-03-15 |
2015-06-02 |
Insite Vision Corporation |
Concentrated aqueous azalide formulations
|
CN103965273B
(zh)
|
2013-08-23 |
2016-05-25 |
普莱柯生物工程股份有限公司 |
一种大环内酯类化合物
|
US20150141328A1
(en)
*
|
2013-11-18 |
2015-05-21 |
The Schepens Eye Research Institute |
Stimulation of human meibomian gland function
|
AR102810A1
(es)
|
2014-08-18 |
2017-03-29 |
Taisho Pharmaceutical Co Ltd |
Derivado de macrólido sustituido en la posición c-4
|
JP7049355B2
(ja)
|
2017-02-22 |
2022-04-06 |
アイエスアール イミューン システム レギュレイション ホールディング アクチエボラグ(パブル) |
新規免疫刺激化合物
|
EA037729B1
(ru)
|
2017-02-22 |
2021-05-14 |
АйЭсАр ИММЬЮН СИСТЕМ РЕГЬЮЛЕЙШН ХОЛДИНГ АБ (ПАБЛ) |
Новый иммуностимулирующий макролид
|
CN116507362A
(zh)
|
2020-09-03 |
2023-07-28 |
Isr免疫***调节控股公共有限公司 |
包含抗原和tlr2激动剂的疫苗
|